rs199818971

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_001159702.3(FHL1):​c.797G>A​(p.Arg266Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,208,996 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R266W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.000030 ( 0 hom. 9 hem. )

Consequence

FHL1
NM_001159702.3 missense

Scores

2
2
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.55

Publications

1 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26398277).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000301 (33/1097998) while in subpopulation NFE AF = 0.0000344 (29/841984). AF 95% confidence interval is 0.0000242. There are 0 homozygotes in GnomAdExome4. There are 9 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 9 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001159702.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
NM_001159702.3
MANE Plus Clinical
c.797G>Ap.Arg266Gln
missense
Exon 7 of 8NP_001153174.1Q13642-2
FHL1
NM_001159699.2
MANE Select
c.737-520G>A
intron
N/ANP_001153171.1Q13642-5
FHL1
NM_001440769.1
c.845G>Ap.Arg282Gln
missense
Exon 6 of 7NP_001427698.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
ENST00000394155.8
TSL:5 MANE Plus Clinical
c.797G>Ap.Arg266Gln
missense
Exon 7 of 8ENSP00000377710.2Q13642-2
FHL1
ENST00000370683.6
TSL:1 MANE Select
c.737-520G>A
intron
N/AENSP00000359717.1Q13642-5
FHL1
ENST00000543669.5
TSL:1
c.689-520G>A
intron
N/AENSP00000443333.1Q13642-1

Frequencies

GnomAD3 genomes
AF:
0.00000901
AC:
1
AN:
110998
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000110
AC:
2
AN:
181049
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000124
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000301
AC:
33
AN:
1097998
Hom.:
0
Cov.:
31
AF XY:
0.0000248
AC XY:
9
AN XY:
363432
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26397
American (AMR)
AF:
0.0000284
AC:
1
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54136
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40513
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4101
European-Non Finnish (NFE)
AF:
0.0000344
AC:
29
AN:
841984
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46069
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000901
AC:
1
AN:
110998
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
33192
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30420
American (AMR)
AF:
0.00
AC:
0
AN:
10501
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3529
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2559
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5957
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
52998
Other (OTH)
AF:
0.00
AC:
0
AN:
1477
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000831
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)
-
1
-
X-linked myopathy with postural muscle atrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.26
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.5
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.57
N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.97
D
Vest4
0.21
MutPred
0.42
Loss of methylation at R266 (P = 0.0334)
MVP
0.87
MPC
1.5
ClinPred
0.52
D
GERP RS
3.5
Varity_R
0.46
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199818971; hg19: chrX-135291510; COSMIC: COSV61780957; COSMIC: COSV61780957; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.